Press Releases
Media Contact:
Lorie Calvo
425-608-3008
Northwest Biotherapeutics Q3 loss widens as costs grow
LONDON, Nov. 15, 2007 (Thomson Financial delivered by Newstex) -- Northwest Biotherapeutics (OTCBB:NWBO) Inc said its third-quarter loss widened on higher costs.
The US-based biotechnology company posted a widened third-quarter loss of 3.90 mln usd compared with 1.80 mln last year. The company's total operating expenses increased to 3.56 mln usd compared with 1.42 mln last year.
|
